---
title: "Janus Living, Inc. Stock 12‑Month Price Target Raised to $29.45, Implies 16% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288618705.md"
description: "Janus Living, Inc.'s average 12-month price target was raised to $29.45 from $29 by 11 analysts, implying a 16% upside based on the June 2 closing price. Forecasts range from $26 to $34. The consensus rating remains 'Buy', with 10 analysts recommending Buy and 1 holding."
datetime: "2026-06-03T19:20:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288618705.md)
  - [en](https://longbridge.com/en/news/288618705.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288618705.md)
generator: "portal-rs"
---

# Janus Living, Inc. Stock 12‑Month Price Target Raised to $29.45, Implies 16% Upside

-   According to estimates from 11 analysts, Janus Living, Inc. stock's average price target has risen from $29 to $29.45, with forecasts ranging from $26 to $34 per share
-   Based on the Jun. 2 closing price, the updated target implies approximately 16% potential upside
-   Consensus rating remains at “Buy” across 11 covering analysts, with 10 Buys, 1 Holds and 0 Sells

Explore more price target data and ratings for Janus Living, Inc. on the , and track all previous and future analyst recommendations for Janus Living, Inc. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [JAN.US](https://longbridge.com/en/quote/JAN.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Tribe Property Technologies Inc. reports Q2 results](https://longbridge.com/en/news/296953133.md)
- [Does Interparfums’ (IPAR) Earnings Upgrade Hint At Deeper Strength In Its Profit Model?](https://longbridge.com/en/news/296564505.md)
- [EarthLabs Inc. GAAP EPS of $0.01](https://longbridge.com/en/news/296951906.md)
- [LSL Pharma Group Inc. reports Q2 results](https://longbridge.com/en/news/296953883.md)
- [Keep This Renewable Energy Stock Close Until November](https://longbridge.com/en/news/296821932.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**